UCB Ventures is a strategic corporate venture fund established in 2017. The firm invests in the innovative therapeutics and technology platforms that are early stage and higher risk in areas adjacent to UCB's therapeutic focus on neurology/neurodegenerative diseases, immunology and muscular-skeletal/bone health. It is based in Brussels, Belgium with a regional office in London, England.